Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality

Author:

Han Hui-Chen12,Wang Jia3,Birnie David H.4,Alings Marco5,Philippon François6,Parkash Ratika7,Manlucu Jaimie8,Angaran Paul9,Rinne Claus10,Coutu Benoit11,Low R. Aaron12,Essebag Vidal1314,Morillo Carlos15,Healey Jeffrey S.16,Redfearn Damian17,Toal Satish18,Becker Giuliano14,DeGrâce Michel19,Thibault Bernard20,Crystal Eugene21,Tung Stanley22,LeMaitre John23,Sultan Omar24,Bennett Matthew25,Bashir Jamil1,Ayala-Paredes Felix26,Gervais Philippe6,Rioux Leon27,Hemels Martin E. W.2829,Bouwels Leon H. R.30,Exner Derek V.14,Dorian Paul9,Connolly Stuart J.3,Longtin Yves31,Krahn Andrew D.1

Affiliation:

1. Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada

2. Victorian Heart Institute, Monash University, Clayton, Victoria, Australia

3. Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada

4. Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada

5. Division of Cardiology, Amphia Ziekenhuis & Working Group on Cardiovascular Research the Netherlands (WCN), Breda, the Netherlands

6. Division of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Quebec City, Quebec, Canada

7. Division of Cardiology, Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia, Canada

8. Division of Cardiology, Lawson Health Research Institute, London Health Sciences, Western University, London, Ontario, Canada

9. Division of Cardiology, Department of Medicine, University of Toronto, St Michael Hospital, Toronto, Ontario, Canada

10. Division of Cardiology, St Mary’s General Hospital, Kitchener, Ontario, Canada

11. Division of Cardiology, Centre hospitalier de l’Université de Montréal (CHUM), University of Montreal, Montreal, Quebec, Canada

12. Division of Cardiology, Chinook Regional Hospital, Lethbridge, Alberta, Canada

13. Division of Cardiology, McGill University Health Center, Montreal, Quebec, Canada

14. Division of Cardiology, Hôpital du Sacré-Coeur de Montréal, University of Montreal, Montreal, Quebec, Canada

15. Division of Cardiology, Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada

16. Division of Cardiology, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada

17. Division of Cardiology, Kingston General Hospital, Queen’s University, Kingston, Ontario, Canada

18. Division of Cardiology, Horizon Health Network, Saint John, New Brunswick, Canada

19. Division of Cardiology, Hôtel-Dieu de Lévis, Levis, Montreal, Quebec, Canada

20. Division of Cardiology, Montreal Heart Institute, Montreal, Quebec, Canada

21. Division of Cardiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

22. Division of Cardiology, St Paul’s Hospital, University of British Columbia, Vancouver, British Columbia, Canada

23. Division of Cardiology, Royal Columbian Hospital, New Westminster, British Columbia, Canada

24. Division of Cardiology, Regina General Hospital, Saskatchewan Health Authority, Regina, Saskatchewan, Canada

25. Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada

26. Division of Cardiology, Centre Hospitalier Universitaire de Sherbrooke (CHUS), Sherbrooke, Montreal, Quebec, Canada

27. Division of Cardiology, Centre Intégré de Sante et Service Sociaux du Bas-Laurent (CISSSBSL), Rimouski, Montreal, Quebec, Canada

28. Division of Cardiology, Rijnstate Hospital, Arnhem, the Netherlands

29. Division of Cardiology, Radboud University Medical Centre, Nijmegen, the Netherlands

30. Division of Cardiology, Canisius Wilhelmina Ziekenhuis, Nijmegen, the Netherlands

31. Jewish General Hospital Sir Mortimer B. Davis, McGill University, Montreal, Quebec, Canada

Abstract

ImportanceCardiac implantable electronic device (CIED) infection is a potentially devastating complication with an estimated 12-month mortality of 15% to 30%. The association of the extent (localized or systemic) and timing of infection with all-cause mortality has not been established.ObjectiveTo evaluate the association of the extent and timing of CIED infection with all-cause mortality.Design, Setting, and ParticipantsThis prospective observational cohort study was conducted between December 1, 2012, and September 30, 2016, in 28 centers across Canada and the Netherlands. The study included 19 559 patients undergoing CIED procedures, 177 of whom developed an infection. Data were analyzed from April 5, 2021, to January 14, 2023.ExposuresProspectively identified CIED infections.Main Outcomes and MeasuresTime-dependent analysis of the timing (early [≤3 months] or delayed [3-12 months]) and extent (localized or systemic) of infection was performed to determine the risk of all-cause mortality associated with CIED infections.ResultsOf 19 559 patients undergoing CIED procedures, 177 developed a CIED infection. The mean (SD) age was 68.7 (12.7) years, and 132 patients were male (74.6%). The cumulative incidence of infection was 0.6%, 0.7%, and 0.9% within 3, 6, and 12 months, respectively. Infection rates were highest in the first 3 months (0.21% per month), reducing significantly thereafter. Compared with patients who did not develop CIED infection, those with early localized infections were not at higher risk for all-cause mortality (no deaths at 30 days [0 of 74 patients]: adjusted hazard ratio [aHR], 0.64 [95% CI, 0.20-1.98]; P = .43). However, patients with early systemic and delayed localized infections had an approximately 3-fold increase in mortality (8.9% 30-day mortality [4 of 45 patients]: aHR, 2.88 [95% CI, 1.48-5.61]; P = .002; 8.8% 30-day mortality [3 of 34 patients]: aHR, 3.57 [95% CI, 1.33-9.57]; P = .01), increasing to a 9.3-fold risk of death for those with delayed systemic infections (21.7% 30-day mortality [5 of 23 patients]: aHR, 9.30 [95% CI, 3.82-22.65]; P < .001).Conclusions and RelevanceFindings suggest that CIED infections are most common within 3 months after the procedure. Early systemic infections and delayed localized infections are associated with increased mortality, with the highest risk for patients with delayed systemic infections. Early detection and treatment of CIED infections may be important in reducing mortality associated with this complication.

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3